Companies: 10,795·Total market cap: $144.5T
Longduoduo Company Limited

Longduoduo Company Limited

LDDDOTCHealthcare● Active
$0.93
+$0.42(+83.14%)
Market Cap$28034044
P/E Ratio
52W High$4.99
52W Low$0.51

Longduoduo Company Limited (LDDD) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

lddd · pe ratio · data through Jun 30, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Longduoduo Company Limited (LDDD) measures how much investors pay for each dollar of the company's trailing earnings. LDDD's current PE ratio of N/A is calculated by dividing its stock price of $0.93 by its TTM earnings per share of -$0.01.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30

Forward P/E
N/A
EPS (TTM)
-$0.01
TTM · diluted EPS
PEG Ratio
0.58
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Longduoduo Company Limited SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2021 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 225.3x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Longduoduo Company Limited
Longduoduo Company LimitedYou
LDDD
$28MN/A-$0.01
Cadrenal Therapeutics, Inc. Common Stock
Cadrenal Therapeutics, Inc. Common Stock
CVKD
$12MN/A-$6.64
Harvard Bioscience, Inc.
Harvard Bioscience, Inc.
HBIO
$27MN/A-$12.77
P3 Health Partners Inc.
P3 Health Partners Inc.
PIII
$40MN/A-$45.26
Precipio, Inc.
Precipio, Inc.
PRPO
$41MN/A-$0.23
Vicarious Surgical Inc.
Vicarious Surgical Inc.
RBOT
$4MN/A-$8.45
Rallybio Corporation
Rallybio Corporation
RLYB
$84MN/A-$1.59

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-06-30Latest
FY2025
325.23x$0.02+159.2%
2024-06-30
FY2024
125.47x$0.04
2023-06-30
FY2023
$-0.00
2022-06-30
FY2022
$-0.25
2021-06-30
FY2021
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Longduoduo Company Limited (LDDD) measures how much investors pay for each dollar of the company's trailing earnings. LDDD's current PE ratio of N/A is calculated by dividing its stock price of $0.93 by its TTM earnings per share of -$0.01.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.93 ÷ -$0.01 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

LDDD pe ratio · 6 questions

LDDD's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.93 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via LDDD's SEC 10-K and 10-Q filings.

LDDD PE ratioWhat is LDDD PE ratioCurrent PE ratio of LDDDLDDD PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Longduoduo Company Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09